Price $36.75 |
Market Cap
1.23B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
2.88
|
P/S
2.38
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
62.3
|
Op. Cash Flow
24.8K
|
FCF
0.5
|
|
Op. Margin
0.90%
|
Net Margin
-4.70%
|
ROE
-5.60%
|
ROI
0.70%
|
|
ROA
-3.40%
|
EPS Growth
-168.70%
|
Current Ratio
3.3
|
Debt/Equity
36.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Valeant Pharmaceuticals Intl I (VRX) | $24.27 | - | - | 7.68B | Strong Buy |
| Opiant Pharmaceuticals Inc (OPNT) | $14.86 | - | - | 44.2M | Strong Buy |
| Bovie Medical Corporation (BVX) | $4.11 | - | - | 128.9M | Strong Buy |
| Hologic, Inc. (HOLX) | $40.46 | - | - | 10.34B | Strong Buy |
| Aralez Pharmaceuticals Inc (ARLZ) | $0.39 | - | - | 27.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
